The Dermatology Digest

SEPTEMBER 30, 2024

market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

The Dermatology Digest

SEPTEMBER 9, 2024

“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. Liu Yi, Sisram Chairman and Executive Director, in a news release.

Portfolios 36

Portfolios Dermatology Injections Marketing 36

Spa Executive

NOVEMBER 10, 2023

As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. Under the mentorship of Susan Harmsworth, she honed her skills in areas like spa therapies, aromatherapy, wellness operations, design, marketing, and public relations.

Portfolios 52

Portfolios Hospital Partnerships Branding 52

Spa Executive

JULY 17, 2024

Catherine Warren is Vice President of Strategic Partnerships at Arch Amenities Group, a provider of comprehensive amenity management and consulting services for hotels, residential complexes, and commercial real estate. Moreover, I’m excited about the prospect of scaling our impact through education and training initiatives.

Technology 98

Technology Hospital Sustainability Innovations 98

AAAMS

JANUARY 4, 2023

Additionally, look into your market and similar practices in the area, which will be your competition. The program aims to help you pinpoint your personal business goals, allowing you to transition to and succeed in the aesthetic medicine field. Further, compare a few insurance policies to ensure you’re covered.

Entrepreneurship 52

Entrepreneurship Networking Social Media Partnerships 52

The Dermatology Digest

DECEMBER 21, 2023

“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

“We are increasingly optimistic about the near-term potential that the next-generation technology in the Evolysse and Estyme fillers lines will offer customers in the fast-growing facial HA market. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36